Poulton Jeffrey V. - Insider Transactions
Insider Type
individual
Companies
1
Average
61,465
Total Txns
75
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 25 | -25 | 0.00 | 1,031,135.39 | -1,031,135.39 |
| 2025 | 0 | 50 | -50 | 0.00 | 3,578,733.42 | -3,578,733.42 |
| Total: | 0 | 75 | 10 | 0.00 | 4,609,868.81 | -4,609,868.81 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
450.81 USD |
704 Sold |
317,370 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
449.79 USD |
324 Sold |
145,732 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
428 Sold |
194,214 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
451.86 USD |
432 Sold |
195,204 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
447.92 USD |
73 Sold |
32,698 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
452.69 USD |
869 Sold |
393,388 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
455.82 USD |
95 Sold |
43,303 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
454.84 USD |
317 Sold |
144,184 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
448.77 USD |
234 Sold |
105,012 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
446.53 USD |
150 Sold |
66,980 USD |
01/10/2025 | 02/10/2025 |